LRA-Supported Researcher Finds Similarity between COVID-19 and Lupus Flares
October 21, 2020 In a recent study published in Nature Immunology, LRA Lupus Insight Prize recipient Dr. Ignacio Sanz and colleagues found that the immune response in patients hospitalized with severe COVID-19 was different from that in patients with mild disease, and that the immune response in severely ill COVID-19 patients was more like a lupus flare. They saw that among severely ill COVID-19 patients, some immune cells called B cells reproduced unchecked, and […] READ MORE
Researchers Make Strides in Predicting COVID-19 Response, New LRA Study Finds
October 15, 2020 Some people respond to COVID-19 by releasing high amounts of immune proteins called cytokines, which form when the body detects a foreign invader. But release of excessive amounts of cytokines leads to a large immune response that can cause organ damage. With grant support from the Lupus Research Alliance, Dr. Roberto Caricchio […] READ MORE
LRA-Funded Study Pinpoints a Key Player in Lupus Nephritis as Target for New Treatments
October 8, 2020 People with lupus often develop complications in major organs such as the kidneys, called Lupus Nephritis (LN). By taking pictures of the kidneys with a special microscope, Dr. Janos Peti-Peterdi and his team at Keck School of Medicine of University of Southern California (USC) found a chain of molecules that leads to […] READ MORE
LRA-Supported Study Confirms Two Targets for Drugs in Development
October 1, 2020 In a recent Lupus Research Alliance supported study published in Frontiers in Immunology, Dr. Ziaur Rahman linked molecules called TLR7 and type II interferon to impairing the ability of immune cells to do their job. These findings support further development by several companies of lupus treatments that block TLR7 and type II […] READ MORE
The Lupus Research Alliance Presents 2020 Lupus Insight Prize Recipient – Dr. Jane Salmon
New York, NY. September 25, 2020 — The Lupus Research Alliance presented its 2020 Lupus Insight Prize to Jane Salmon, MD for her work in improving the health of pregnant women with lupus and antiphospholipid syndrome. The prize was formally “presented” to Dr. Salmon by LRA Scientific Advisory Board Chair Gary Koretzky, MD during a […] READ MORE
Lupus Clinical Trials Redefined: You Make the Difference
Lupus Clinical Trials Redefined: You Make the Difference Lupus Clinical Trials Virtual Fair October 17, 2020 10:00 am to 1:00 pm ET Register Here Lupus clinical trials are still underway despite COVID-19. Making the process safer and easier for patients has never been more important. What is a clinical trial exactly? Why should I get involved […] READ MORE
LRA Applauds GSK on Positive Phase 3 Study of Benlysta® in Lupus Nephritis
September 16, 2020 NEW YORK, NY. The Lupus Research Alliance welcomes positive BLISS-LN Phase 3 data published in this week’s New England Journal of Medicine, demonstrating that GSK’s drug Benlysta® (belimumab) significantly improved kidney function in adults with lupus nephritis, the most common severe complication of lupus causing inflammation and serious damage to the kidney. The […] READ MORE
Lupus Therapeutics Collaborating with PPD to Accelerate Lupus Clinical Research
September 3, 2020 PPD, Inc. issued a press release today announcing its collaboration with the Lupus Research Alliance affiliate Lupus Therapeutics to optimize lupus clinical research among its pharmaceutical and biotech clients. As a contract research organization, PPD helps its clients design and implement clinical trials. PPD expects to gain from Lupus Therapeutics’ deep clinical […] READ MORE
23andMe Study Confirms Lupus Can Run in Families and Other New Insights
August 25, 2020 A study started four years ago and conducted by 23andMe provided many insights about lupus as a complex disease that is extremely difficult to diagnose and treat. While the survey of nearly 6,000 participants did not find new genetic factors causing lupus as hoped, the study confirmed that lupus can run in […] READ MORE
Family Night with GoGo squeeZ
Go Go with Us for Family Fun Night August 26! Enjoy a light-hearted demonstration of a nutritious kid-friendly recipe, celebrate fundraising successes with outstanding Walk Team Captains and hear an insider preview of the first and largest virtual lupus Walk Event September 12. EVENT DATE | TIME August 26, 7:00 PM Eastern Time PROGRAM Welcome […] READ MORE
Study Suggests Older Lupus Patients May Stop Hydroxychloroquine Without Raising Risk for Flares
August 18, 2020 A newly published study conducted by many of the research investigators who receive grant support from the Lupus Research Alliance found that older people with lupus may be able to discontinue their use of hydroxychloroquine. Investigators conducted this study because prolonged use of the drug can cause side effects like blurred vision […] READ MORE
Watch Webcast Video: Redefining Lupus Trials Amid COVID-19 and Beyond
Videotape of 8.24.20 Learn from Lupus Zoom Webcast Ensuring the clinical trial process is accommodating for participants has always been the goal. However, COVID-19 has forced industry, research organizations, doctors, and patients to think twice about the process and its impact on high-risk populations including people with lupus who are immunocompromised. In light of COVID-19, […] READ MORE
